| 期 |
栏目 |
标题 |
文件 |
| 编号 17 (2015) |
Articles |
Rezul'taty monitoringa effektivnosti i bezopasnosti primeneniya preparatov rekombinantnogo insulina cheloveka Biosulin R i Biosulin N u bol'nykh sakharnym diabetom 2 tipa v real'noy klinicheskoy praktike |
|
| 编号 5 (2017) |
Articles |
EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE |
|
| 编号 4 (2018) |
Articles |
MOSCOW EXPERIENCE OF APPLICATION OF A NEW LONG-ACTING INSULIN ANALOGUE |
|
| 编号 11 (2018) |
Articles |
Initiation of insulin therapy in patients with type 2 diabetes mellitus according to the Federal Diabetes Register in Moscow |
|
| 编号 11 (2018) |
Articles |
Type 1 diabetes mellitus in Moscow -2018 (according to the Moscow segment of the Federal Diabetes Register) |
|
| 卷 26, 编号 4 (2019) |
Articles |
Experience of the use of insulin degludec in the treatment of patients with type 1 diabetes mellitus (according to the data of the Moscow segment of the Federal Diabetes Register) |
|
| 卷 26, 编号 14 (2019) |
Articles |
Start of therapy of type 2 diabetes mellitus with a fixed combination. Metformin with vildagliptin or glibenclamide, is there any difference? |
|
| 卷 26, 编号 14 (2019) |
Articles |
Experience in the integrated use of organizational approaches and clinical tools to achieve glycemic control goals |
|
| 卷 26, 编号 14 (2019) |
Articles |
What can affect the effectiveness of basal insulin therapy for patients with type 2 diabetes mellitus: analysis of the results of real clinical practice according to the diabetes register |
|
| 卷 27, 编号 12 (2020) |
Articles |
Modern approaches to using the FreeStyle Libre Flash glucose monitoring system |
|
| 卷 28, 编号 4 (2021) |
Articles |
Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice |
|
| 卷 28, 编号 4 (2021) |
Articles |
New possibilities of using the FreeStyle Libre Flash-glucose monitoring system. FreeStyle Libre software ecosystem in Russia |
|
| 卷 29, 编号 4 (2022) |
Articles |
The use of the last generation insulin analogues for the control of diabetes mellitus in real clinical practice |
|
| 卷 29, 编号 11/12 (2022) |
Articles |
Place of GLP-1 receptor antagonists and SGLT-2 inhibitors in modern therapy of type 2 diabetes mellitus |
|
